NABRIVA THERAPEUTICS PLC - ADR Chart calendar Nabriva Therapeutics PLC - ADR
e57dfa17b612.a22dDYaKMQK_BR7-SVWxXZ8Zi_BWTcVIY79oDqeNC7c.AlnvWO_EYVjRS0fLHQHGG6dg8cI4JYF9FYkQd__CXf4FAtFsstp0S_NpKg~247b2917e34e8c2a85185fa3762c364b
Upcoming events on Nabriva Therapeutics PLC - ADR
No events available
Past events on Nabriva Therapeutics PLC - ADR
| 2022-11-10 04:30 pm | Q3 2022 Earnings Call |
| 2022-11-10 04:01 pm | Q3 2022 Earnings Release |
| 2022-09-11 | H.C. Wainwright Global Investment Conference |
| 2022-08-11 12:00 pm | Annual General Meeting |
| 2022-08-03 04:30 pm | Interim 2022 Earnings Call |
| 2022-08-03 04:01 pm | Interim 2022 Earnings Release |
| 2022-05-24 07:00 am | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-05 04:30 pm | Q1 2022 Earnings Call |
| 2022-05-05 04:01 pm | Q1 2022 Earnings Release |
| 2022-03-29 04:30 pm | FY 2021 Earnings Call |
| 2022-03-29 04:01 pm | FY 2021 Earnings Release |
| 2022-01-18 02:00 pm | Extraordinary Shareholders Meeting |
| 2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
| 2021-11-18 03:00 am | Jefferies London Healthcare Conference |
| 2021-11-09 04:30 pm | Q3 2021 Earnings Call |
| 2021-11-09 04:01 pm | Q3 2021 Earnings Release |
| 2021-10-17 11:45 am | American College of Chest Conference |
| 2021-09-28 | Infectious Disease Society of America Meeting |
| 2021-09-13 07:00 am | H.C. Wainwright Global Investment Conference |
| 2021-08-05 04:30 pm | Interim 2021 Earnings Call |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,66 9,58 0.78% | 9,48 10,6 -10.3% | 5,03 4,11 22.2% | 28,9 29,7 -2.82% |
|
EBITDA Million USD | Released Forecast Spread | -114 -103 -10.72% | -79,1 -78,6 -0.59% | -65,7 -64,0 -2.67% | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -114 -105 -8.42% | -79,5 -82,2 3.24% | -66,1 -61,5 -7.48% | -48,5 -46,1 -5.25% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -115 -107 -7.57% | -82,7 -86,8 4.81% | -69,3 -60,5 -14.6% | -49,0 -46,5 -5.39% |
|
Net income Million USD | Released Forecast Spread | -115 -106 -8.68% | -82,8 -84,8 2.43% | -69,5 -60,7 -14.45% | -49,5 -47,0 -5.21% |
|
EPS USD | Released Forecast Spread | -565 -521 -8.36% | -280 -287 2.47% | -135 -121 -12.01% | -28,5 -27,3 -4.59% |
| Announcement Date | 12/03/19 | 12/03/20 | 11/03/21 | 29/03/22 |
Quarterly results
| Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,24 5,99 37.71% | 8,86 7,46 18.74% | 9,26 10,1 -8.3% | 8,02 9,58 -16.24% | 9,19 8,53 7.75% | 9,15 10,7 -14.26% |
|
EBIT Million USD | Released Forecast Spread | -11,4 -12,8 11.41% | -10,8 -11,1 2.26% | -12,9 -10,5 -23.14% | -11,6 -11,5 -0.83% | -10,4 -11,6 10.7% | -11,2 -10,6 -5.48% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,1 -13,2 15.44% | -10,9 -11,2 2.61% | -13,1 -10,6 -23.59% | -11,5 -11,7 1.59% | -10,7 -11,8 9.15% | -11,0 -10,9 -0.89% |
|
Net income Million USD | Released Forecast Spread | -11,8 -13,2 10.84% | -10,7 -11,2 4.86% | -13,1 -10,6 -23.08% | -11,8 -11,7 -1.45% | -11,1 -11,8 5.87% | -11,5 -10,9 -5.66% |
|
EPS USD | Released Forecast Spread | -7,25 -8,67 16.35% | -5,25 -5,83 10% | -6,00 -4,75 -26.32% | -5,00 -4,75 -5.26% | -4,50 -5,00 10% | -4,21 -4,03 -4.6% |
| Announcement Date | 05/08/21 | 09/11/21 | 29/03/22 | 05/05/22 | 03/08/22 | 10/11/22 |
More events
